tiprankstipranks
SourceBio International Plc (GB:SBI)
LSE:SBI
UK Market

SourceBio International Plc Stock Analysis & Ratings

GB:SBI Stock Chart & Stats

Day’s Range121.15p - 121.15p
52-Week Range151.00p - 239.25p
Previous Close127p
Volume400.00
Average Volume (3M)169.64K
Market CapN/A
P/E Ratio6.2
Beta-1.20
Next EarningsSep 27, 2022
EPS ForecastN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Smart Score6
EPS (TTM)0.22


SourceBio International Plc News

Currently, no data available
Please return soon. This page is being updated.

---

Financials

Yearly

P/E Ratio Range

The price to earnings ratio. This is used by investors to assess a stock’s market price relative to its earnings.

---

GB:SBI FAQ

What was SourceBio International Plc’s price range in the past 12 months?
SourceBio International Plc lowest stock price was 151.00p and its highest was 239.25p in the past 12 months.
    What is SourceBio International Plc’s market cap?
    Currently, no data Available
    What is SourceBio International Plc’s price target?
    The average price target for SourceBio International Plc is 220.00p. This is based on 1 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
    The highest analyst price target is 220.00p ,the lowest forecast is 220.00p. The average price target represents 81.59% Increase from the current price of 121.15p.
      What do analysts say about SourceBio International Plc?
      SourceBio International Plc’s analyst rating consensus is a ‘Moderate Buy. This is based on the ratings of 1 Wall Streets Analysts.
        When is SourceBio International Plc’s upcoming earnings report date?
        SourceBio International Plc’s upcoming earnings report date is Sep 27, 2022 which is in 132 days.
          How were SourceBio International Plc’s earnings last quarter?
          SourceBio International Plc released its earnings results on Apr 05, 2022. The company reported 11.9p earnings per share for the quarter, beating the consensus estimate of N/A by 11.9p.
            Is SourceBio International Plc overvalued?
            According to Wall Street analysts SourceBio International Plc’s price is currently Undervalued.
              Does SourceBio International Plc pay dividends?
              SourceBio International Plc does not currently pay dividends.
              What is SourceBio International Plc’s EPS estimate?
              SourceBio International Plc’s EPS estimate for its next earnings report is not yet available.
              How many shares outstanding does SourceBio International Plc have?
              Currently, no data Available
              What happened to SourceBio International Plc’s price movement after its last earnings report?
              SourceBio International Plc reported an EPS of 11.9p in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went up 13.043%.
                Which hedge fund is a major shareholder of SourceBio International Plc?
                Currently, no hedge funds are holding shares in GB:SBI

                ---

                SourceBio International Plc Stock Analysis

                Analyst Forecast

                Moderate Buy
                Average Price Target: 220.00p

                Blogger Sentiment

                Bullish
                GB:SBI Sentiment 100% Sector Average 71%

                Hedge Fund Holdings

                N/A
                Currently Not Enough Data Available

                Insider Transactions

                ▲ Bought Shares
                Worth £129.5K over the Last 3 Months

                Retail Investors

                N/A
                Currently Not Enough Data Available

                News Sentiment

                N/A
                Currently Not Enough Data Available

                Technicals

                SMA
                Negative
                20 days / 200 days
                Momentum
                -25.29%
                12-Months-Change

                Fundamentals

                Return on Equity
                41.71%
                Trailing 12-Months
                Asset Growth
                49.86%
                Trailing 12-Months
                The SourceBio International Plc stock analysis is based on the TipRanks Smart Score which is derived from 8 unique data sets including Analyst recommendations, Crowd Wisdom, Hedge Fund Activity, Media Sentiment and multiple Technical stock factors. The Smart Score is a quantitative, data-driven rating system and does not include human intervention.
                Learn more about TipRanks Smart Score

                Company Description

                SourceBio International Plc

                SourceBio International PLC is an international provider of integrated laboratory services and products to clients in the healthcare, clinical, life science research and biopharma industries, with a focus on improving patient diagnosis, management and care. Its revenues are derived from four core businesses areas namely Healthcare Diagnostics; Genomics; Stability Storage; and Infectious Disease Testing. The offerings will provide a broad range of infectious disease testing across the NHS, private healthcare and commercial sectors in the future.

                ---
                Similar Stocks
                No data currently available

                Popular Stocks

                ---
                What's Included in PREMIUM?
                Make informed decisions based on Top Analysts' activity
                Know what industry insiders are buying
                Get actionable alerts from top Wall Street Analysts
                Find out before anyone else which stock is going to shoot up
                Get powerful stock screeners & detailed portfolio analysis